Join NETRF’s ‘Research Changes Lives’ Giving Tuesday Campaign—Every gift doubled now through December 3, 2024. LEARN MORE
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
Home » For Researchers » Past Symposia » 2023 Research Symposium » 2023 Research Symposium Videos
The 2023 Margie & Robert E. Petersen Research Symposium was held on November 15-17 at the beautiful waterfront InterContinental Hotel in Boston, Massachusetts. The Symposium is designed each year to bring together researchers from around the world to learn from each other by sharing the most current neuroendocrine tumor research.
The 2023 Symposium had 120 attendees and included 29 presentations by NET researchers from around the world. Oral presentations were divided by NET topic focus, resulting in five sessions, each hosted by two moderators with talks covering basic, translational, and clinical research projects. Each of the talks was followed by a Q&A period, and each session ended with a panel discussion that included all session speakers.
SESSION 1: PERSONALIZED MEDICINE
SESSION CHAIRS: Chrissie Thirlwell, MBBS, PhD, University of Bristol Medical School & James Bibb, PhD, University of Arizona Medical School – Phoenix
SESSION 2: IMPROVING RADIOTHERANOSTICS
SESSION CHAIRS: Daniel Halperin, MD, University of Texas MD Anderson Cancer Center & Martyn Caplin, MD, University College London & Royal Free Hospital
SESSION 3: NET PATHWAYS & TARGETS
SESSION CHAIRS: Dawn Quelle, PhD, University of Iowa & Justin Annes, MD, PhD, Stanford University
SESSION IV: TUMOR EVOLUTION & MICROENVIRONMENT
SESSION CHAIRS: Minah Kim, PhD, Columbia University & Iacovos Michael, PhD, Sunnybrook Research Institute
SESSION V: IMMUNOTHERAPIES
SESSION CHAIRS: Jennifer Eads, MD, University of Pennsylvania & Carl Gay, MD, PhD, University of Texas MD Anderson Cancer Center